These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21336261)

  • 21. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
    Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA
    J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas.
    Uguen A; Uguen M; Guibourg B; Talagas M; Marcorelles P; De Braekeleer M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):361-367. PubMed ID: 27490764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions.
    Keller-Melchior R; Schmidt R; Piepkorn M
    J Invest Dermatol; 1998 Jun; 110(6):932-8. PubMed ID: 9620301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
    Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
    Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
    Krengel S; Grotelüschen F; Bartsch S; Tronnier M
    J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polypoid Compound Melanocytic Proliferations: A Clinicopathological Study.
    Mesbah Ardakani N; Harvey NT; Wood BA
    Am J Dermatopathol; 2019 Aug; 41(8):578-584. PubMed ID: 31335410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
    Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
    Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
    Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
    Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosinase and nestin immunohistochemical expression in melanocytic nevi as a histopathologic pattern to trace melanocyte differentiation and nevogenesis.
    Murtas D; Pilloni L; Diana A; Casula L; Tomei S; Piras F; Ferreli C; Maxia C; Perra MT
    Histochem Cell Biol; 2019 Feb; 151(2):175-185. PubMed ID: 30232588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma.
    Birindelli S; Tragni G; Bartoli C; Ranzani GN; Rilke F; Pierotti MA; Pilotti S
    Int J Cancer; 2000 Apr; 86(2):255-61. PubMed ID: 10738254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas.
    Kiszner G; Wichmann B; Nemeth IB; Varga E; Meggyeshazi N; Teleki I; Balla P; Maros ME; Penksza K; Krenacs T
    Virchows Arch; 2014 May; 464(5):603-12. PubMed ID: 24682564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanocytic proliferations associated with lichen sclerosus.
    Carlson JA; Mu XC; Slominski A; Weismann K; Crowson AN; Malfetano J; Prieto VG; Mihm MC
    Arch Dermatol; 2002 Jan; 138(1):77-87. PubMed ID: 11790170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunohistochemical analysis of ras gene expression in human melanomas and melanocytic nevi].
    Yasuda H
    Hokkaido Igaku Zasshi; 1989 May; 64(3):243-53. PubMed ID: 2670726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation.
    Kelly JW; Crutcher WA; Sagebiel RW
    J Am Acad Dermatol; 1986 Jun; 14(6):1044-52. PubMed ID: 3722481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi.
    Hussein MR; Sun M; Tuthill RJ; Roggero E; Monti JA; Sudilovsky EC; Wood GS; Sudilovsky O
    J Cutan Pathol; 2001 Aug; 28(7):343-50. PubMed ID: 11437939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D1 and D3 expression in melanocytic skin lesions.
    Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
    Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of clinicopathologic characteristics of 422 conjunctival melanocytic nevi specimens].
    Zhang ZB; Liang QF; Huang JJ; Li B
    Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):583-587. PubMed ID: 28851198
    [No Abstract]   [Full Text] [Related]  

  • 40. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.